Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula M Cannon

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Cell Stem Cell|December 7, 2019
Gene Editing Expands the Donor Pool for CCR5-Negative Stem Cell TransplantsPaula M Cannon
Blood|April 8, 2016
The clinical applications of genome editing in HIVCathy X Wang, Paula M Cannon
Hematology/Oncology Clinics of North America|September 13, 2017
Gene Therapy Approaches to Human Immunodeficiency Virus and Other Infectious DiseasesGeoffrey L Rogers, Paula M Cannon
AIDS Patient Care and Stds|November 18, 2016
Clinical Applications of Genome Editing to HIV CureCathy X Wang, Paula M Cannon
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 26, 2021
The genome-editing decadePaula M Cannon, Hans-Peter Kiem
Virus Research|February 28, 2002
Use of pseudotyped retroviral vectors to analyze the receptor-binding pocket of hemagglutinin from a pathogenic avian influenza A virus (H7 subtype)Amy H Lin, Paula M Cannon
Human Gene Therapy|September 5, 2007
Promoter choice for retroviral vectors: transcriptional strength versus trans-activation potentialErin L Weber, Paula M Cannon
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 26, 2021
Genome edited B cells: a new frontier in immune cell therapiesGeoffrey L Rogers, Paula M Cannon
Journal of Virology|February 26, 2005
Functional domains within the human immunodeficiency virus type 2 envelope protein required to enhance virus productionPaolo Abada, Beth Noble, Paula M Cannon
Viruses|January 25, 2013
A systems biology starter kit for arenavirusesMagali E Droniou-Bonzom, Paula M Cannon
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Cell Stem Cell|December 7, 2019
Gene Editing Expands the Donor Pool for CCR5-Negative Stem Cell TransplantsPaula M Cannon
Blood|April 8, 2016
The clinical applications of genome editing in HIVCathy X Wang, Paula M Cannon
Hematology/Oncology Clinics of North America|September 13, 2017
Gene Therapy Approaches to Human Immunodeficiency Virus and Other Infectious DiseasesGeoffrey L Rogers, Paula M Cannon
AIDS Patient Care and Stds|November 18, 2016
Clinical Applications of Genome Editing to HIV CureCathy X Wang, Paula M Cannon
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 26, 2021
The genome-editing decadePaula M Cannon, Hans-Peter Kiem
Virus Research|February 28, 2002
Use of pseudotyped retroviral vectors to analyze the receptor-binding pocket of hemagglutinin from a pathogenic avian influenza A virus (H7 subtype)Amy H Lin, Paula M Cannon
Human Gene Therapy|September 5, 2007
Promoter choice for retroviral vectors: transcriptional strength versus trans-activation potentialErin L Weber, Paula M Cannon
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 26, 2021
Genome edited B cells: a new frontier in immune cell therapiesGeoffrey L Rogers, Paula M Cannon
Journal of Virology|February 26, 2005
Functional domains within the human immunodeficiency virus type 2 envelope protein required to enhance virus productionPaolo Abada, Beth Noble, Paula M Cannon
Viruses|January 25, 2013
A systems biology starter kit for arenavirusesMagali E Droniou-Bonzom, Paula M Cannon
Pageof 6